Metformin affects alternative splicing of the estrogen receptor alpha gene in breast cancer cells
Creators
- 1. Department of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Fukuoka University, 8-19-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan.
- 2. Department of Regenerative Medicine & Transplantation, Faculty of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan
Description
ABSTRACT
Metformin ameliorates insulin resistance and reported to have prophylactic potential in breast cancer. The estrogen receptor-alpha gene is known to be alternatively spliced to the ERα46 isoform with decreased expression in tamoxifen-resistant breast cancer cells. We show here that metformin had a differential effect on its alternative splicing in MCF-7 and its tamoxifen-resistant derivative, TAMR1 cells. Metformin altered the tamoxifen-induced expression of ERα46 and treatment of cell-transplanted nude mice showed decreased tumor weight only in TAMR1 cell tumors. This is the first report to show metformin specifically involved in alternative splicing of genes in breast cancer cells.
Keywords: Estrogen receptor-alpha (ERα), estrogen, tamoxifen, metformin
Files
AJPHR1011001.pdf
Files
(1.4 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:ce452973040949493761bc1ace0ad2c0
|
1.4 MB | Preview Download |